1115 related articles for article (PubMed ID: 15866165)
41. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells.
van der Horst G; van der Werf SM; Farih-Sips H; van Bezooijen RL; Löwik CW; Karperien M
J Bone Miner Res; 2005 Oct; 20(10):1867-77. PubMed ID: 16160745
[TBL] [Abstract][Full Text] [Related]
43. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
44. Wnt signaling control of bone cell apoptosis.
Bodine PV
Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
[TBL] [Abstract][Full Text] [Related]
45. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts.
Vaes BL; Dechering KJ; van Someren EP; Hendriks JM; van de Ven CJ; Feijen A; Mummery CL; Reinders MJ; Olijve W; van Zoelen EJ; Steegenga WT
Bone; 2005 May; 36(5):803-11. PubMed ID: 15820155
[TBL] [Abstract][Full Text] [Related]
46. [Regulation of osteoclast differentiation by Wnt signals].
Kobayashi Y
Clin Calcium; 2013 Jun; 23(6):831-8. PubMed ID: 23719495
[TBL] [Abstract][Full Text] [Related]
47. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
Yavropoulou MP; Yovos JG
Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
[TBL] [Abstract][Full Text] [Related]
48. The role of the Wnt/β-catenin pathway in the effect of implant topography on MG63 differentiation.
Wang W; Zhao L; Ma Q; Wang Q; Chu PK; Zhang Y
Biomaterials; 2012 Nov; 33(32):7993-8002. PubMed ID: 22889483
[TBL] [Abstract][Full Text] [Related]
49. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
50. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin.
Albers J; Keller J; Baranowsky A; Beil FT; Catala-Lehnen P; Schulze J; Amling M; Schinke T
J Cell Biol; 2013 Feb; 200(4):537-49. PubMed ID: 23401003
[TBL] [Abstract][Full Text] [Related]
51. Transmembrane protein 64 reciprocally regulates osteoblast and adipocyte differentiation by modulating Wnt/β-catenin signaling.
Jeong BC; Kim TS; Kim HS; Lee SH; Choi Y
Bone; 2015 Sep; 78():165-73. PubMed ID: 25979161
[TBL] [Abstract][Full Text] [Related]
52. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.
Gori F; Hofbauer LC; Dunstan CR; Spelsberg TC; Khosla S; Riggs BL
Endocrinology; 2000 Dec; 141(12):4768-76. PubMed ID: 11108292
[TBL] [Abstract][Full Text] [Related]
53. LGR4 acts as a key receptor for R-spondin 2 to promote osteogenesis through Wnt signaling pathway.
Zhu C; Zheng XF; Yang YH; Li B; Wang YR; Jiang SD; Jiang LS
Cell Signal; 2016 Aug; 28(8):989-1000. PubMed ID: 27140682
[TBL] [Abstract][Full Text] [Related]
54. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
[TBL] [Abstract][Full Text] [Related]
55. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
[TBL] [Abstract][Full Text] [Related]
56. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.
Fei Y; Xiao L; Doetschman T; Coffin DJ; Hurley MM
J Biol Chem; 2011 Nov; 286(47):40575-83. PubMed ID: 21987573
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
58. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.
Qiu W; Hu Y; Andersen TE; Jafari A; Li N; Chen W; Kassem M
J Biol Chem; 2010 May; 285(19):14438-49. PubMed ID: 20223822
[TBL] [Abstract][Full Text] [Related]
59. Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.
Haxaire C; Haÿ E; Geoffroy V
Am J Pathol; 2016 Jun; 186(6):1598-609. PubMed ID: 27083516
[TBL] [Abstract][Full Text] [Related]
60. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.
Frey JL; Li Z; Ellis JM; Zhang Q; Farber CR; Aja S; Wolfgang MJ; Clemens TL; Riddle RC
Mol Cell Biol; 2015 Jun; 35(11):1979-91. PubMed ID: 25802278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
